Neogen Corporation
Neogen Corporation (NEOG) Revenue
Annual & quarterly revenue history · segment & region breakdown
NEOG · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsNeogen Corporation trailing twelve-month (TTM) revenue is $0.87B, a decrease of 3.20% year-over-year from $0.89B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-05-31 | $0.89B | -$0.03B | -3.20% |
| 2024-05-31 | $0.92B | +$0.10B | +12.37% |
| 2023-05-31 | $0.82B | +$0.30B | +56.01% |
| 2022-05-31 | $0.53B | +$0.06B | +12.53% |
| 2021-05-31 | $0.47B | +$0.05B | +12.03% |
| 2020-05-31 | $0.42B | +$0.00B | +0.96% |
| 2019-05-31 | $0.41B | +$0.02B | +4.09% |
| 2018-05-31 | $0.40B | +$0.04B | +11.07% |
| 2017-05-31 | $0.36B | +$0.04B | +11.52% |
| 2016-05-31 | $0.32B | +$0.04B | +13.50% |
Compare revenue vs peers
Medical - Diagnostics & ResearchCompare NEOG revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Neogen Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Neogen Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Neogen Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
NEOG revenue · 4 questionsNEOG's trailing twelve-month (TTM) revenue is $0.87B. That is a decrease of 3.20% year-over-year from $0.89B in FY2025.
▸ Source: FMP · Neogen Corporation SEC filings · GAAP · Neogen Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026